Clinical Trial

ELEVATE-HFpEF Clinical Study

Study acronym: ELEVATE-HFpEF
Recruiting
View on ClinicalTrials.gov →
Summary
ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart failure with preserved ejection fraction (HFpEF).
Protocol Amendment History 3 changes
notable Trial sites expanded: 46 -> 50 locations 2026-08-04
notable Trial sites expanded: 34 -> 42 locations 2026-05-05
notable Trial sites expanded: 28 -> 34 locations 2026-03-31
Trial Details
NCT Number NCT06678841
Lead Sponsor Medtronic Cardiac Rhythm and Heart Failure
Conditions Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment 700 participants
Start Date 2025-07-09
Primary Completion 2028-08 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-03